Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, will participate in the 2025 RBC Capital Markets Global Healthcare Conference. The company's senior management team will partake in a fireside chat on Wednesday, May 21 at 10:00 a.m. ET in New York, NY. A live webcast of the discussion will be available on the Company's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE90626) on May 19, 2025, and is solely responsible for the information contained therein.